Evaluation of the Effect of the Association of Proton Pump Inhibitor

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04999904` - A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability	N/A
Completed	`NCT01518335` - Use of Platelet Rich Plasma Therapy for Acute Ankle Sprains in the Emergency Department	N/A
Completed	`NCT01995318` - Effectiveness of Kinesiotaping in the Treatment of Acute Ankle Sprains	N/A
Completed	`NCT01066520` - TAASS-Traumeel Ointment and Gel Compared With a Topical NSAID in Athletes With Acute Ankle Sprain	Phase 3

See also

Status

Clinical Trial

Phase

Recruiting

NCT04999904 - A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability

N/A

Completed

NCT01518335 - Use of Platelet Rich Plasma Therapy for Acute Ankle Sprains in the Emergency Department

N/A

Completed

NCT01995318 - Effectiveness of Kinesiotaping in the Treatment of Acute Ankle Sprains

N/A

Completed

NCT01066520 - TAASS-Traumeel Ointment and Gel Compared With a Topical NSAID in Athletes With Acute Ankle Sprain

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00717119
Study type	Observational
Source	AstraZeneca
Contact
Status	Completed
Phase	N/A
Start date	April 2008
Completion date	August 2008

Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms